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ABSTRACT OF THESIS

ASSESSING MALNUTRITION IN LIVER DISEASE PATIENTS BEING
EVALUATED FOR TRANSPLANT USING THE NUTRITION FOCUSED
PHYSICAL EXAM

Patients with liver disease have an increased risk for malnutrition because of side
effects of the disease. The Nutrition Focused Physical Exam (NFPE) was developed
for nutrition professionals to aid physicians in a nutrition-based diagnosis of
malnutrition. The purpose of this study was to examine the NFPE for its validity in
liver disease patients being evaluated for transplant. In addition, the NFPE was used
to assess incidence and severity of malnutrition in end stage liver disease patients
and compare these results to already developed malnutrition tools such as the
Patient Generated-Subjective Global Assessment (PG-SGA), Triceps Skinfolds
(TSF), Mid-Arm Circumference (MAC), Lumbar Index, and Total Psoas Muscle
Area (TPA). The NFPE was found to be highly correlated with PG-SGA results.
There was a weak correlation between the NFPE and the TSF, MAC, and Lumbar
Index/TPA, except when comparing the bottom 25% quartile of the Lumbar Index
to severe malnutrition using the NFPE. This resulted in a moderate correlation. The
odds-ratio for hospital admission based on malnutrition and severe malnutrition
were both extremely high (14.571, 18.857 respectively). These preliminary results
reinforce the significance of the NFPE and the need for additional studies using this
tool.
KEY WORDS: Cirrhosis, Malnutrition, Nutrition Focused Physical Exam,
Transplant, PG-SGA
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Chapter 1: Introduction
End stage organ disease and organ transplantation, is rapidly growing. According
to the United Network for Sharing Organs, better known as UNOS, there has been a
19.8% increase in growth of organ transplants since 2012.[1] This is mainly due to an
increase in deceased donors and changes in medical criteria that would have previously
resulted in clinicians declining the use of an organ. Since the first organ transplant
occurred in 1954, over 700,000 people have received transplants offering an extension on
life in the U.S. [1, 3] Liver transplantation for end stage liver disease (ESLD), is a major
section of this population. ESLD affects 1 in 10 Americans, or roughly 30 million
Americans.[3] The most common causes of liver disease are from the hepatitis virus,
heavy alcohol use, non-alcoholic fatty liver disease (NAFLD), liver cancer, and
autoimmune diseases. Patients with NAFLD, liver cancer, and cirrhosis from the hepatitis
virus are rising in number, and may be related to the obesity epidemic, previous nonscreening of blood products for the hepatitis virus, and drug use in the U.S. [3]
End stage liver disease can lead to many health complications such as
ascites/edema which may require paracentesis or draining, decline in kidney function,
encephalopathy or confusion, enlarged blood vessels, infection, or decline in respiratory
function.[3] A common complication of end stage liver disease is malnutrition, which can
greatly affect a patient’s quality of life outcomes.[4-8] Malnutrition is common in
patients with liver disease because of their increased metabolic demands, side effects of
the disease such as malabsorption, and changes in eating habits such as decreased
appetite or nausea. [4, 9, 10] Additionally, mild to moderate malnutrition is common in
chronic disease such as organ failure, due to the continuous level of inflammation.[11]
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This mild to moderate degree of malnutrition can advance to severe malnutrition if it is
left unrecognized or untreated.[12]
Malnutrition is prevalent in 15-60% of the adult patient population, but many of
the methods used to assess malnutrition are expensive, unreliable, or have limitations.[12]
The range for prevalence of malnutrition varies widely due to the differences in patient
population and tools used to assess malnutrition. Some tools are very in-depth, while
others are simply based on appetite and weight loss. Common tools used to assess for
malnutrition are protein levels (albumin and prealbumin), malnutrition screening tools
which use a questionnaire, or anthropometric measurements such as triceps skin folds
(TSF), mid-arm circumference (MAC), and hand-grip strength.[11, 12] These tools can
be affected by medical conditions and inter-observer reliability. These tools can be
expensive to conduct, leading to inconsistent and potentially unreliable malnutrition
diagnoses.
In 2012, the Academy of Nutrition and Dietetics (AND) and the American
Society for Parenteral and Enteral Nutrition (ASPEN) released a Consensus Statement on
the identification and documentation of malnutrition in the adult population.[12]
According to White et al. (2012), “there is currently no universally accepted approach to
the diagnosis and documentation of adult malnutrition.” White et al. (2012) in
conjunction with AND and ASPEN, developed a set of parameters and characteristics for
qualified nutrition professionals to aid physicians in a nutrition-based diagnosis of
malnutrition. Thus, the Nutrition Focused Physical Exam (NFPE) was created for
assessing malnutrition in all of the adult patient population. (See Appendix B)
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Problem Statement
The focus of this study is to use the Nutrition Focused Physical Exam (NFPE),
developed by the Academy of Nutrition and Dietetics and American Society for Enteral
and Parenteral Nutrition, to identify and assess the severity of malnutrition in end stage
liver disease patients being evaluated for transplant. In addition, the NFPE will be studied
for its validity and effectiveness in this specific patient population.
Purpose
According to a recent literature search, only one published study has assessed
malnutrition using the NFPE.[13] This study was conducted in head and neck cancer
patients and the results may not apply to all patient populations. More studies need to be
conducted using the NFPE to determine its use in different adult patient populations. This
study will use the NFPE to assess incidence and severity of malnutrition in ESLD
patients and compare these results to already developed malnutrition tools.

Research Questions
1. How does the NFPE relate to current tools such as Patient GeneratedSubjective Global Assessment (PG-SGA), Triceps Skinfolds (TSF), Mid-Arm
Circumference (MAC), and Lumbar Index/Psoas Muscle Area in End Stage
Liver Disease Patients?
2. How prevalent is malnutrition in ESLD patients using the NFPE for
diagnosis?
3. How does malnutrition diagnosed using the NFPE relate to patient outcomes?
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Research Hypotheses
1. There is a positive correlation between the NFPE and current tools such as
PG-SGA, MAC, TSF, and the Lumbar Index/Psoas Muscle Area, when
assessing malnutrition in ESLD patients.
2. Malnutrition is prevalent in at least half of all ESLD patients using the NFPE
for diagnosis.
3. ESLD patients with a malnutrition diagnosis using the NFPE are more likely
to result in a patient outcome such as hospital admission, decompensation,
listing for transplant, transplant, and death.

Justification
Malnutrition may be prevalent in “ 65-90% of patients with cirrhosis, and in up to
100% in patients waiting for liver transplantation”.[14] Many side effects of ESLD, such
as ascites, may mask the incidence and severity of malnutrition in these patients when
using available methods such as BMI and weight loss.[4, 9, 10] There has been some
success in previous studies using hand grip strength, MAC, SGA, and TST. However,
there are still limitations to using these methods.[10, 15]
AND and ASPEN developed the NFPE in 2011. The tool shows promise to be
used successfully in many adult patient populations to assess the incidence and severity
of malnutrition. However, to our knowledge, there has only been one published study to
date that used the NFPE to assess malnutrition in the adult population. The NFPE is
intended to be an affordable, simple, and reliable method for assessing malnutrition and
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can be used in a variety of patient populations. Therefore, it is imperative to conduct
more research using the NFPE to assess malnutrition in multiple populations, including
those with ESLD, and hopefully, establishing this tool as a “gold standard” for assessing
malnutrition.

Chapter 2: Literature Review

Introduction:
Malnutrition in ESLD patients is a widespread issue that can lead to many health
complications and poor outcomes in this patient population. Many studies evaluated
ESLD and the role of malnutrition.[6, 8-10, 14, 16-18] However, there are many
limitations to these studies, mainly due to the tools used to assess malnutrition. At this
point in time, there is no “gold standard” tool that is cheap, easy to use, and valid for
assessing malnutrition. The purpose of this study is to look at ESLD patients being
evaluated for transplant, and to assess for malnutrition using the NFPE. Liver disease
diagnosis and a patient’s MELD (model for end stage liver disease) score will also be
examined in ESLD patients and will be compared to the NFPE results.

End Stage Liver Disease
The most common causes of ESLD are Hepatitis B and C, acute liver failure,
autoimmune hepatitis, alcoholic liver disease, nonalcoholic fatty liver
disease/nonalcoholic steatohepatitis, hepatocellular carcinoma, primary biliary cirrhosis,
and primary sclerosis cholangitis.[2, 3] There are other causes of ESLD, but they are not
as commonly seen. Table 1 (see below) provides a summary of these diseases.
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Table 1: Summary of Common Liver Disease Diagnoses[2, 3]
Type of Liver
Disease

Hepatitis B and C

Cause of Liver
Disease

Hepatitis is a virus
that can be
transmitted through
bodily fluids (semen,
blood, and vaginal
secretions)

At Risk
Populations/Risk
Factors

Treatment/Cure

• IV drug use
• Unprotected sex
• Body piercings
• Tattoos
• Incarceration

• Hepatitis can be cured spontaneously by
the body and through pharmaceuticals.
• There is currently a vaccine for
Hepatitis B, but not for Hepatitis C.
• When a patient with the hepatitis virus
fails treatment, or waits too long to seek
treatment, it can lead to liver damage and
ultimately liver failure. This can only be
treated with transplant.

• High
acetaminophen
use
• Herbal use
• Cancers with
high risk of liver
metastasis
development
• Liver Cancer
• Metabolic
Disorders
• Women
between the ages
15-40
• Other
autoimmune
diseases
• Alcoholics
• Those with long
history of
frequent alcohol
use

Acute Liver Failure

Drug overdose
(acetaminophen),
drug
toxicity/reaction,
herbal supplements,
viruses, cancer,
metabolic diseases

Autoimmune
Hepatitis

Immune system
attacks liver cells
causing inflammation
and damage

Alcoholic Liver
Disease

Alcohol abuse

Nonalcoholic Fatty
Liver
Disease/Nonalcoholic
Steatohepatitis

Build-up of fat cells
in the liver

• Obesity
• Diabetes
• High cholesterol
• Unhealthy diet

• Healthy diet and exercise
• Weight loss if overweight/obese
• Transplant

Hepatocellular
Carcinoma

Liver Cancer

• Pre-existing
cirrhosis
• Long term
hepatitis virus

• Resection
• Chemoembolization
• Ablation
• Treatment of hepatitis or underlying
cirrhosis
• Transplant

Primary Biliary
Cirrhosis

Destruction of
intrahepatic bile
ducts leads to build

• Women
• Middle age

• Symptom management with
medications
• Transplant
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• Medications to reverse poisoning
• Transplant

• Suppress immune system with steroids
or other immunosuppressant drugs
• Transplant

• Alcohol cessation
• Transplant

Table 1: Summary of Common Liver Disease Diagnoses (continued) [2, 3]
up of bile and scar
tissue, damaging the
liver.

adults
• Genetics

Primary Sclerosis
Cholangitis

Blocked bile ducts
due to scar tissue and
inflammation leads to
buildup of bile,
damaging the liver.

• Men
• Genetics
• Exact cause
unknown

• Symptom management with
medications and surgery
• Transplant

Other (less common)

Wilson’s Disease,
Hemochromatosis,
Alpha-1
Anti-trypsin
Deficiency,
Undetermined cause,
etc.

• Genetics
• Lifestyle

• Treatment based on disease.
• Transplant

ESLD has many different causes and components to its development. The most
common indication that liver disease has reached end stage or organ failure, is the
development of decompensation.[16] The development of decompensation in liver
disease occurs when there is diffuse scarring in the liver and it loses its ability to fully
function.[3, 10] Decompensation in liver disease results in various health issues such as
hepatocellular carcinoma (HCC), ascites that may require frequent paracentesis (LVP) or
drainage, esophageal varices (EV), hepatorenal syndrome (HRS), jaundice, hepatic
encephalopathy (HE), spontaneous bacterial peritonitis (SBP) and kidney insufficiency.
While decompensation is a useful indicator of ESLD, many patients do not develop these
symptoms until later in the disease. Therefore, clinicians have developed additional tools
and resources, such as MELD Score and Child-Turcotte-Pugh Score, to assess the
severity of ESLD in transplant patients.

MELD Score and Liver Disease
Until 2001, the tool used to assess the severity of liver disease for organ allocation
was the Child-Turcotte-Pugh Score (CTP). Using clinic measurements such as: albumin,
prealbumin, and prothrombin time lab values, and the subjective evaluation of the degree
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of ascites and encephalopathy, CTP was used to determine the overall severity of the
liver disease.[16] Mayo Clinic developed the model for end stage liver disease (MELD)
in 2000. MELD was used in patients undergoing the transjugular intrahepatic
portosystemic shunt (TIPS) procedure as a tool to predict survival.[19] In 2002, UNOS
adapted the MELD for use in predicting the 3-month mortality of patients awaiting liver
transplant. Switching from CTP to MELD score decreased mortality on the waiting list
15% and wait time from 656 to 300 days.[16] In the study conducted by Ahmad,
Downey, Akoad, and Cacciarelli (2007), they found that Veterans were transplanted
faster after switching to MELD score for listing, and there was an increase in
prioritization of sicker patients for transplant on the waiting list.[20] The drastic
improvement in wait time and decreased mortality on the waiting list, is why MELD
scores are now seen as superior to CTP in ESLD patients.
One reason that MELD score is favored for transplant listing is that objective
data, instead of subjective data like that used in CTP is used to create the score. A score
from 6-40 is used to rate the severity of illness. This is calculated based on bilirubin,
prothrombin time, and creatinine lab values.[16, 21] These scores can vary as patient’s
liver function improves or worsens. UNOS uses this MELD score to prioritize organs to
sicker patients. The higher the score, the more likely a patient is to be transplanted.
According to Leise et al. (2011), a MELD score  15 has a favorable benefit-risk ratio for
transplant and patients with a MELD > 10 should be referred for liver transplant. While
the MELD score has been shown to decrease liver transplant wait time and improved
mortality while waiting on the list, there are still drawbacks to the scoring system. One of
the major drawbacks of the score, is the missing components of nutritional and functional
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status.[22] With malnutrition being so widespread in this patient population, it is
important to determine how malnutrition and MELD are related as a potential indicator
for mortality in ESLD patients waiting for transplant. Limited research with a broad array
of malnutrition assessment tools makes consistent evaluation difficult. One aspect of this
study is to find if there is a correlation between MELD score and degree of malnutrition
in ESLD patients using the recently developed NFPE.

Malnutrition in Liver Disease
Malnutrition in liver disease is extremely common due to many factors.
According to Strasser & Vidot (2011), malnutrition may be prevalent “in 65-90% of
patients with cirrhosis, and in up to 100% in patients waiting for liver transplantation.”
Malnutrition in ESLD patients has been shown to further complicate their health, by
increasing their risk of developing infections, ascites, hepatorenal syndrome, and hepatic
encephalopathy.[9, 14] Understanding the mechanisms and causes of the development of
malnutrition in cirrhosis patients is key in their prevention and diagnosis.
Malnutrition in ESLD patients is recognized as a form of undernutrition or
inadequate intake of nutrients, which can be influenced by a variety of factors. Often,
resulting in muscle and fat loss, nutrient deficiencies, and poor outcomes. Those with
ESLD have common nutrition-related side effects that include decreased appetite, early
satiety due to ascites, abdominal pain with possible nausea and bloating caused by
decreased gastric motility of indigestion, and impaired absorption secondary to portal
hypertension and cholestatic liver disease.[10, 17] Impaired absorption from liver disease
prevents the body from completely absorbing nutrients or foods ingested or decreases the
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ability to use the nutrients consumed as adequately as the body should. These patients
also have increased calorie and protein needs due to their hypermetabolic state.[17]
The hypermetabolic state in ESLD, as a result of chronic inflammation, promotes
the breakdown of proteins and causes an increase in energy expenditure.[17] The release
of pro-inflammatory cytokines and alcohol intake leads to a hypermetabolic state
resulting in poor appetite and anorexia.[9, 17] Anorexia, hypermetabolism, and nutritionrelated side effects from liver disease are important components in the development of
malnutrition.
Patients with ESLD are often prescribed different diets based on their diagnosis,
weight, presence of decompensation, and level of muscle and fat loss. These diets are
tailored for specific patient needs to help with symptom management and to prevent
future side effects as the liver disease progresses. A low sodium, high protein diet is the
general recommendation for liver disease patients to reduce ascites/edema development
and prevent protein catabolism or breakdown.[10] As ascites increases or appetite
decreases, patients are recommended to eat small, frequent meals and include a bedtime
snack to increase calorie and protein intake, thus preventing long periods of fasting.
Patients with a diagnosis of NASH or NAFLD are recommended to lose weight, while
consuming adequate amounts of protein due to the catabolic state of their cirrhosis.[10]
Adhering to these diets can be challenging for patients, and may play a role in the
development of malnutrition.
Nutrition-related side effects and hypermetabolism, are not the only factors that
drive a patient’s malnutrition. The nature of the recommended diet for patients with
cirrhosis itself can also make it difficult to meet nutritional goals. Maintaining adequate
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nutrition while following a low sodium diet is especially difficult for ESLD patients.[14]
Decreased palatability of food without salt and limited number of food options that are
high in calories and protein but low in sodium can make it difficult for patients to
maintain a satisfactory nutritional status, especially without the help of nutrition expert. A
decreased intake of foods and impaired absorption may lead to micronutrient deficiencies
such as zinc and magnesium, which can lead to taste changes (metallic, foul, rancid) and
further decrease their intake.[9]
It is also still commonplace for practitioners to recommend patients follow a low
protein diet for encephalopathy prevention, even though this was found to be inaccurate,
and can be detrimental to a patient’s nutritional status.[14, 23] In a randomized study
conducted by Cordoba et al. in 2004, there was no difference seen in development and
course of encephalopathy between normal protein and low protein diet groups.
Furthermore, higher protein catabolism was seen in the patients on the low protein diet,
providing further evidence of why protein should not be restricted in this population.[24]
Even with evidence to the contrary, many clinicians still recommend cirrhotic patients
follow a low-protein diet, either from misinformation or lack of knowledge surrounding
current research, further complicating their health.
Protein needs are high in ESLD patients. Their hypermetabolic state leads to an
increased breakdown of protein, while complications from cirrhosis can lead to increased
protein losses in ascites, during paracentesis, and in blood loss from varices.[10, 17] The
decrease in liver function itself, can also lead to decreased protein stores. Cirrhotic livers
produce an insufficient amount of protein and have reduced capacity to store proteins in
the liver. A continual decreased intake of protein in liver disease, can drive the body into
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a metabolic state comparable to starvation.[10, 14] Even an overnight fast without protein
can throw the body into this “starvation” mode due to the cirrhotic liver’s decreased
glycogen reserves. These decreased glycogen reserves cause the body to create energy
through gluconeogenesis and lipolysis.[14]
When the body uses these alternate sources of fuel, amino acids are pulled from
the muscle for gluconeogenesis, and fat stores are used for lipolysis.[17] This leads to
muscle wasting and fat loss that is commonly seen in end stage cirrhotic patients. The
presence of decompensation also increases the risk of developing malnutrition in liver
disease patients.[10] The nutrition-related side effects we commonly see in these patients,
the decreased function of the liver, inability to meet nutritional needs from decreased
appetite and dietary restrictions, and the high calorie and protein needs all contribute to
the weight loss, muscle loss, and fat loss seen in ESLD patients. This contributes to, an
increased risk of developing malnutrition.
Previous studies have used different methods to assess the degree of malnutrition
in liver patients. The Subjective Global Assessment (SGA) and anthropometric measures
such as BMI and weight loss/gain, mid-arm muscle circumference (MAMC), mid-arm
circumference (MAC), triceps skin fold (TSF), hand grip strength with dynamometer, and
blood protein levels are all common tools that have been used to assess the degree of
malnutrition in liver patients.[10, 17] Anthropometrics such as BMI and weight loss/gain
is especially hard to use as an evaluator of malnutrition due to the large volume of ascites
that is typically found in ESLD patients. NASH/NAFLD patients are typically obese and
signs of muscle loss can be masked.[9, 10] Merli et al. (2011) and Johnson et al. (2013)
discussed how measuring protein stores/levels, such as albumin and prealbumin as
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indicators of nutritional status, have been used in previous studies but can be unreliable in
ESLD patients. This is due to the already decreased production of proteins in the liver
and their response to inflammation. While protein stores, BMI, and weight changes have
limitations when assessing malnutrition in liver disease patients, there are some tools that
are fairly useful and can be used in this population.
The SGA, MAMC, MAC, TSF, and hand grip strength have been relatively
successful in previous studies for evaluating malnutrition in liver disease patients, but
still have limitations.[9, 14, 15, 17] MAMC, MAC, and TSF can be good tools to use in
ESLD because they are not affected by ascites and edema, but there could be inter- and
intra-observer variability if they are not properly trained. Alveres-Da Silva & Silveira
(2005), compared hand grip strength, SGA, and nutritional index derived from lab values
and TSF, and determined that hand grip strength can be a reliable measure, but none of
these assessment tools can be considered a “gold standard” alone. A simple, cheap, and
more effective method needs to be developed. The purpose of this study is to explore
newly developed malnutrition assessment tools in the search of this “gold standard”.

Lumbar Index and Muscle Loss

Sarcopenia, or loss of muscle mass, is frequently an issue in chronic illness such
as ESLD. Muscle loss is often the result of poor nutritional status or malnutrition, a
common characteristic in cirrhosis patients, and is often used to assess the severity of
malnutrition. Measuring nutritional status is often unreliable or subjective. Therefore,
research into measuring sarcopenia with objective tools, such as CT scans, has become of
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recent interest. These tools are especially useful in this patient population due to ascites
and fat mass potentially masking evidence of muscle loss.
A study conducted by Durand et al. (2014) looked at the muscle thickness of the
psoas muscle to assess for sarcopenia. This muscle is in the lumbar region of the spine
and was studied at the level of the umbilicus. The psoas muscle has been shown to
correlate to whole body muscle mass, and is relatively easy to see on scans, making it an
ideal measure of muscle loss.[25] This study examined psoas muscle thickness in ESLD
patients waiting for transplant. Decreased psoas muscle thickness were shown to be
predictive of mortality, independent of MELD score, while on the waiting list. Durand et
al. (2014), also found this to be true in the patients with lower MELD scores (<25) who
also had refractory ascites. This is especially important because of the role of MELD and
ascites in the ESLD patient. Assessing muscle loss in these patients is often difficult due
to their ascites, and MELD scores do not always accurately reflect mortality risk because
they lack a nutritional component. MELD scores were also shown to underestimate
mortality risk in this study and refractory ascites was believed to be a component in the
development of muscle loss in these patients.[25] However, there are limitations to using
this tool to assess muscle loss or sarcopenia. These scans are not low in cost, they can be
affected by osteoporosis or spinal fractures, and they are not as easy to frequently
reassess in a patient as a MELD score. While this tool is not perfect, is it is very useful as
an objective tool for measuring sarcopenia in ESLD patients.
In the study conducted by Montano-Loza et al. (2012), sarcopenia was studied as
a predictor of mortality compared to MELD scores. The patients used in this study were
being evaluated for transplant. All patients underwent a routine CT scan as part of their

14

evaluation. The third lumbar (L3) vertebrae was studied on these scans for sarcopenia
using a skeletal muscle index (SMI).[22] The results of this study showed no correlation
between sarcopenia and MELD, CTP, or albumin levels in these patients. A higher
mortality rate was found in the patients with sarcopenia and was related to sepsis-related
death instead of death from liver failure. When using tools such as MELD/CTP as sole
indicators of mortality in ESLD patients, without including nutritional or functional
status, there may be an underestimation in a patient’s risk of mortality.[22] MontanoLoza et al. (2012) notes that CT scans are considered the “gold standard” for diagnosing
sarcopenia, but including measurements of muscle function, such as hand-grip strength,
should be used in the assessment of sarcopenia. These results demonstrate how
sarcopenia can be used to predict mortality. In addition, sarcopenia could be beneficial in
determining MELD scores, which could potentially lead to a more accurate reflection of
mortality risk in ESLD patients.
In a recent study conducted in the U.K., sarcopenia and malnutrition were
assessed and compared to MELD scores in ESLD patients to predict post-transplant
outcomes. Nutritional status and degree of malnutrition were assessed using the validated
Royal Free Hospital Global Assessment (RFH-GA), a tool that is similar to the SGA, that
is used frequently in the U.S. This assessment includes subjective and objective measures
including MAC, TSF, hand grip strength, BMI, and dietary intake.[8] CT scans were
taken to evaluate L3, including the psoas muscle, and were used in the L3-psoas muscle
index (L3-PMI) as a means of comparison. L3-PMI was found to be “positively
correlated with dry weight, BMI, MAC, TSF, handgrip strength, RFH-GA, and MELD”
in this study. However, there was a wide variance in L3-PMI in patients with similar
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MELD scores.[8] This shows how nutritional status is not reflected in MELD scores, but
can be an important predictor of mortality and outcomes. In addition, there was no
correlation found between MELD and RFH-GA scores. Pre-transplant RFH-GA was
associated with worse outcomes and survival, independent of MELD scores.[8]
Kalafetelia et al. (2016) also found that malnutrition and sarcopenia were independent
predictors for post-transplant complications, such as prolonged mechanical ventilation,
longer LOS in ICU and hospital, increased rate of infections, and mortality 1-year after
transplant. RFH-GA even had a stronger correlation with determining post-transplant
outcomes, than L3-PMI.[8] This shows the importance of using nutritional assessments in
predicting post-transplant complications. Using valid nutrition assessments such as RFHGA, with objective tools used to determine muscle loss such as L3-PMI, can improve the
mortality prediction of MELD scores in ESLD patients. An easy, reliable, and valid tool
that encompasses both of these aspects, needs to be developed for use in calculating
MELD scores to better predict 3-month mortality in cirrhosis patients waiting for
transplant.[8]
Recognizing sarcopenia in ESLD patients, is important for their course of
treatment and reduction of complications associated with malnutrition. However, CT
scans are extremely expensive, are not feasible for all populations, are not practical to use
as a frequent tool to monitor sarcopenia, and may be inferior to an overall nutritional
status, especially as a predictor of post-transplant outcomes. The need for a valid,
reliable, all-encompassing tool, is important for prevention and reduction of transplant
outcomes in ESLD patients.
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Nutrition Focused Physical Exams
In 2012, AND and ASPEN formed an international work group assisted by the
European Society for Parenteral and Enteral Nutrition (ESPEN) to standardize markers
and characteristics of malnutrition. AND and ASPEN later released a consensus
statement for identifying and assessing malnutrition.[12] Today, there is no “gold
standard” for identifying malnutrition in the adult patient population. The resources we
have vary widely. Often, they are subjective. This leads to intra-observer variability.
They may also not be specific enough to use between different adult population groups.
When AND and ASPEN released their updated characteristics to detect and diagnose
malnutrition, inflammation, illness vs. environment, and physical characteristics were
added to aid in diagnosis. According to White et al. (2012), to identify malnutrition, two
of the six proposed characteristics need to be present and the characteristics can be
distinguished between non-severe and severe. These characteristics are located below in
Table 2. These characteristics should be assessed upon admission and routinely
throughout patient’s admission/care and should be used to aid physician in diagnosis of
malnutrition. These characteristics have not been validated and will be updated as
research is conducted.
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Table 2: NFPE: Clinical Characteristics to Identify and Support a Diagnosis of
Malnutrition[26]
Clinical
Characteristic

Energy Intake

Malnutrition in the context of
acute illness or injury
Non-severe
(moderate)
malnutrition

Severe
Malnutrition

<75% of
estimated
energy
requirement
for > 7 days

< 50% of
estimated
energy
requirement
for  5 days

%

%

1-2

Interpretation
of Weight
Loss

5
7.5

Time
1 week
1
month
3
months

>2
>5
>7.5

Malnutrition in the context
of chronic illness
Non-severe
(moderate)
malnutrition
< 75% of
estimated
energy
requirement
for  1
month
%
Time

Time
1 week
1
month
3
months

5
7.5
10
20

Severe
Malnutrition
< 75% of
estimated
energy intake
for  1
month
%

Time

1
month
3
months
6
months

>7.5

1 year

>20

>5

>10

Malnutrition in the context of
social or environmental
circumstances
Non-severe
Severe
(moderate)
Malnutrition
malnutrition
£ 50% of
< 75% of
estimated
estimated
energy
energy
requirement
requirement
for  1
for  3
month
months
%
Time
%
Time

1
month
3
months
6
months

>7.5

1 year

>20

>5

>10

1
month
3
months
6
months

>7.5

1 year

>20

>5

>10

1
month
3
months
6
months
1 year

Physical Findings
Body Fat

Mild

Muscle Mass

Mild

Fluid
Accumulation
Reduced Grip
Strength

Mild
N/A

Moderate

Mild

Severe

Mild

Severe

Moderate

Mild

Severe

Mild

Severe

Mild

Severe

Mild

Severe

N/A

Measurably
Reduced

N/A

Measurably
Reduced

Moderate to
Severe
Measurably
Reduced

Since the consensus statement was released, there has been very little research
using the newly defined malnutrition characteristics. In 2016, Mulasi et al. conducted a
study using the new consensus criteria in head and neck cancer patients who were
undergoing cancer treatment. They compared the criteria to other nutrition tools such as
the Subjective Global Assessment (SGA) and bioimpedance methodology to assess for
muscle loss. The bioimpedance methodology is relatively new and is still being studied
for validity.[13] The individuals in this study were assessed with the consensus
characteristics, SGA, and bioimpedance before chemoradiotherapy (CRT) treatment, at
three weeks after beginning treatment, during the last week of treatment, and one and
three months after completion of treatment. There was no significant difference found
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between diagnosis of malnutrition between consensus criteria and SGA. They found good
sensitivity (94%), and moderate specificity (43%). However, there were limitations to
this study. There was a very small population in this study (n=19), it was a single-center
study, and only one participant was female. Many of the components of the NFPE were
validated through other nutrition tools in this study. More research needs to be conducted
using validated tools to compare to the physical findings section of the NFPE.

Conclusion
The purpose of this study is to address the gap in knowledge concerning the
Nutrition Focused Physical Exam (NFPE) such as limited research using the NFPE and
its use in ESLD patients. Additionally, the study will test the validity and reliability of the
NFPE by comparing current, valid, objective tools such as PG-SGA, TST, MAC, and the
Lumbar Index/Psoas Muscle identified through CT scans. Each of these tools will be used
to diagnose malnutrition and will be compared against the NFPE results. In addition, this
tool will be used to identify and assess the severity of malnutrition in ESLD patients
being evaluated for transplant. The findings of this study will examine the NFPE to
determine if it’s a valid tool for assessing malnutrition in ESLD patients.
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Chapter 3: Methods
Study Design:
This was a human based, non-intervention, cross-sectional study, for the
assessment of incidence and severity of malnutrition in end stage liver disease patients
being evaluated for transplant. Malnutrition was determined using multiple tools including
the Subjective Global Assessment (SGA), mid-arm circumference (MAC), triceps skin
fold (TSF), Lumbar Index, Psoas muscle mass, and the Nutrition Focused Physical Exam
(NFPE). These results will be compared to liver disease diagnosis and model for end stage
liver disease (MELD) score. After receiving approval by the University of Kentucky’s
IRB panel, the study was conducted. The study is summarized and described below.
1. The research team obtained consent from patients who are deemed appropriate
for transplant evaluation.
2. The liver transplant team’s scheduling coordinators randomly assigned the
liver transplant dietitian evaluations between the Registered Dietitians (RD) in
the clinic.
3. A RD completed all patient assessments during their initial consult, including
NFPE, SGA, MAC, and TST.
4. Following a CT scan completed during the patient’s initial clinic evaluation,
the research team completed Lumbar Index and Psoas Muscle Area
assessments.
5. The research team maintained contact with the patients’ nurse coordinators for
three-month endpoints, such as incidence of death, listing for transplant,
transplant, development of decompensation, or hospital admissions.
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Subject Recruitment:
Patients were referred to clinic for transplant evaluation from outside providers.
Potential patients were identified from their regularly scheduled clinic visit for liver
transplant evaluation. After a full discussion of the research to be conducted, consent was
obtained by the research team before data was collected for the study. Normal protocol
was followed with all patients regardless of their participation in the study.
Patients in this study were required to have end stage liver disease and deemed
appropriate for liver transplant evaluation. They also had to attend a nutrition evaluation
as part of the standard evaluation process. Patients were excluded from this study if a
patient did not complete the necessary consent form, attend nutritional evaluation as part
of their standard evaluation process, or wish to be part of the research study.

Measurements and Procedures:
All research assessments and procedures were taken during patient’s regularly
scheduled clinic visit with a RD for liver transplant evaluation. Medical history, MELD,
medications, and demographics were taken from patient’s charts or during the visit.
Research assessments and procedures are listed below.
1.

Nutrition Focused Physical Exam (NFPE): The RD administered a physical
exam to assess for muscle loss, fat loss, energy intake, weight loss, fluid
accumulation (related to malnutrition), and hand grip strength. Muscle loss
and fat loss are determined using the Nutrition Focused Physical Exam Pocket
Guide (2015) guidelines and RD’s clinical judgement. Two of the six
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characteristics are needed to make a diagnosis of malnutrition, and can be
used to determine severe vs. non-severe malnutrition.[26] Patients were sitting
upright during assessment and a RD measured for fat loss/muscle in various
parts of the body by gentle touch and manipulation. If any areas of body
needed for assessment were unable to be accessed due to clothing, injury,
edema, or pain, the RD did not assess the area. Energy intake was evaluated
by asking questions on appetite, average % of meals consumed, and duration
that patient has been eating in this manner. Weight loss was calculated based
on dry weights (if available) per patient or by chart review. Hand grip strength
was assessed using a dynamometer in both hands. Patient squeezed the
dynamometer with as much strength as possible in each hand, being careful to
only squeeze once for the measurement. Each measurement was recorded to
the nearest pound or kilogram.
2.

Patient Generated-Subjective Global Assessment (PG-SGA): The PGSGA is a validated tool that expands on the original SGA and was chosen over
the SGA due to the more extensive range of nutrition symptoms and physical
assessment. The PG-SGA assessment data was completed by the RD with the
help of the patient. Data in the assessment includes: weight changes, dietary
intake, gastrointestinal symptoms, functional capacity, physical examination
of fat and muscle loss, edema related to malnutrition, and ascites related to
malnutrition. The physical examination of fat and muscle loss is very similar
to the NFPE, including gentle touch and manipulation of the same body areas,
and did not need to be repeated. Results from the physical exam were used for
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both NFPE and PG-SGA. If any areas of body needed for assessment were
unable to be accessed due to clothing, injury, edema, or pain, the RD did not
assess the area.
3.

Triceps Skin Fold (TSF): The RD located the site midway between the
acromial (shoulder) and elbow. The skin fold was grasped as a vertical fold on
the posterior midline and pulled it away from the muscle. Millimeters of the
skin fold were assessed. If measurements were below the “normal” range,
patients were considered to have malnutrition. The following ranges were
considered normal. [27]

4.



Male: 12.5-7.3 mm



Female: 16.5-9.9 mm

Mid Arm Circumference (MAC): The circumference was measured at the
mid-point between the shoulder and the elbow. The circumference was
assessed for muscle mass. If measurements were below the “normal” range,
patients were considered to have malnutrition. The following ranges were
considered normal.[27]

5.



Male: 29.3-17.5 cm



Female: 28.5-17.1 cm

Lumbar Index: Patients being evaluated for liver transplant received a CT
scan as part of their transplant evaluation. The Lumbar Index is total muscle
surface area at L3 and was evaluated for muscle loss. If measurements were
below the “normal” range, patients were considered to have sarcopenia. The
following ranges were considered normal.[5]
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6.



Males:



Females:

52.4 cm2/m2
38.5 cm2/m2

Psoas Muscle Area: Patients being evaluated for liver transplant received a
CT scan as part of their transplant evaluation. Psoas muscle surface area at L3
was evaluated for muscle loss. If measurements were below the “normal”
range, patients were considered to have sarcopenia. The following ranges
were considered normal.

7.



Males:



Females:

545 mm2/m2
385 mm2/m2

Additional data collected: The RD asked additional questions and collected
data on whether the patient is consuming protein supplements at home and if
they have had previous diet education pertaining to their liver disease.
Albumin levels were also recorded and drawn as part of the patient’s routine
lab work for their transplant evaluation.

Analysis:
Results of the nutrition assessment and radiological data were analyzed by a
member of the research team. Data was analyzed by the research team using SPSS
software version 24 (IBM Inc., Armonk, NY, USA). Data was assessed for normal
distribution, incomplete data, and inaccurate data. Means were compared using the
Mann-Whitney Test. A Spearman’s rho test was conducted to assess for correlation
between the different malnutrition tools. A Fisher’s Exact test was used to compare
malnutrition to patient characteristics such as disease, decompensation, and outcomes
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such as decompensation, listing for transplant, hospital admission, transplant, and death.
An additional logistic regression test was ran to investigate the relationship between
hospital admissions and malnutrition. A p-value of 0.05 or less was determined to be
significant.
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Chapter 4:
Results
Thirty-one patients undergoing liver transplant evaluation and who met inclusion
criteria, participated in this research study. The majority of the participants were male
(77%) and caucasian (96.8%). The median age was 54 years old, with the youngest
participant at 29 years old and the oldest 69 years old. The median BMI was 28.8, with a
range of 15.8-43.9. The median MELD score was (18 6.63) and albumin level (g/dL)
was (2.71.3). These patient characteristics are shown below in Table 3.
Table 3: Age, Sex, Race, MELD, BMI, and Albumin Level Characteristics of Study
Sample

Male
Female

n
24
7

%
77.4%
22.6%

Median
54
-

Std. Deviation
9.9
-

Min
29
-

Max
69
-

Caucasian
African-American

30
1

96.8%
3.2%

-

-

-

-

-

-

18
28.8
2.7

6.63
6.62
0.73

7
15.8
1.3

34
43.9
4.0

Age
Sex
Race

MELD
BMI
Albumin (g/dL)
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Table 4: Diagnosis and Decompensation in Study Sample
n

%

1
3
15
2
10

3.2%
9.7%
48.4%
6.4%
32.3%

27
3
1

87.1%
9.7%
3.2%

30
22
19
21
3
3
1
1
5

96.8%
71%
61.3%
67.8%
9.7%
9.7%
3.2%
3.2%
16.1%

Diagnosis
Autoimmune Hepatitis
Cryptogenic
Alcohol
Hepatitis C
NASH
Secondary Diagnosis
None
HCC
Autoimmune Hepatitis
Decompensation
Ascites
Esophageal Varices
Hepatic Encephalopathy
Large Volume Paracentesis
Hepatorenal Syndrome
Spontaneous Bacterial Peritonitis
Acute Kidney Injury
Hepatopulmonary Syndrome
Chronic Kidney Disease

The majority of these patients either had a diagnosis of alcohol related cirrhosis
(48.4%) or NASH cirrhosis (32.3%). Only four patients had a secondary diagnosis such
as HCC (n=3) or autoimmune hepatitis (n=1). Almost every single patient had a history
of ascites (n=30), and more than half of all patients had history of esophageal varices,
hepatic encephalopathy, or large volume paracentesis. Nearly one-third of the patients
had some form of cirrhosis-related kidney disfunction such as hepatorenal syndrome
(HRS), acute kidney injury (AKI), or chronic kidney disease (CKD). Table 4 contains
these and further diagnoses.
When examining the association between MELD score and cirrhosis diagnosis,
there was a higher median MELD score seen in cryptogenic cirrhosis patients than
alcohol (ETOH) and NASH patients, but there was a wide variability in MELD scores in
each cirrhosis group. Autoimmune hepatitis and Hepatitis C patient groups were excluded
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from this analysis due to their small number size (n=1 and n=2, respectively). The results
are show in Figure 1 below.

Figure 1: MELD Score and Cirrhosis Diagnosis

When examining data on nutrition related variables, only (32.3%) of the patients
endorsed “good” appetite, while the rest noted fair, poor, or no appetite at all. However,
over half of all patients (67.8%) stated that they had some sort of weight loss prior to
evaluation. The median percent body weight loss was (10.8% 9.64), with the highest
amount of percent weight loss at (32.6%). In addition, only 12 patients (38.7%) indicated
that they consumed some sort of protein supplement on a regular basis. Furthermore,
roughly one-third of these patients (35.5%) had never had any type of nutrition-related
diet education. Table 5 shows these results.
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Table 5: Nutrition Related Variables in Study Sample
Variable
Appetite
Good
Fair
Poor
None
Protein Supplement
Previous Diet Education
Weight Loss
% Weight Loss

n

%

Median

Std. Deviation

Min

Max

10
13
7
1
12
20
21

32.3%
41.9%
22.6%
3.2%
38.7%
64.5%
67.8%

-

-

-

-

-

-

10.8

9.64

0

32.6
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NFPE Diagnosis of Malnutrition and Patient Characteristics:
Table 6: Comparison of NFPE Diagnosis of Malnutrition with Decompensation, Patient
Outcomes, MELD score, and Albumin levels.

Diagnosis

Decompensation

Outcomes

MELD

Albumin (g/dL)

Autoimmune
Cryptogenic
Alcohol
Hepatitis C
NASH
Ascites
EV
HE
LVP
HRS
SBP
AKI
HP
CKD
Decompensation
Listing
Hospital
Admission
Transplant
Death

NFPE Diagnosis of Malnutrition
No (n = 7)
Moderate (n
Severe (n =
= 12)
12)
0 (0.0%)
0 (0.0%)
1 (8.3%)
0 (0.0%)
0 (0.0%)
3 (25.0%)
4 (57.1%)
6 (50.0%)
5 (41.7%)
2 (28.6%)
0 (0.0%)
0 (0.0%)
1 (14.3%)
6 (50.0%)
3 (25.0%)
6 (85.7%)
12 (100.0%) 12 (100.0%)
7 (100.0%)
7 (58.3%)
8 (66.7%)
5 (71.4%)
9 (75.0%)
5 (41.7%)
4 (57.1%)
8 (66.7%)
9 (75.0%)
1 (14.3%)
1 (8.3%)
1 (8.3%)
0 (0.0%)
1 (8.3%)
2 (16.7%)
0 (0.0%)
0 (0.0%)
1 (8.3%)
0 (0.0%)
1 (8.3%)
0 (0.0%)
1 (14.3%)
0 (0.0%)
4 (33.3%)
2 (28.6%)
4 (33.3%)
5 (41.7%)
1 (14.3)
6 (50.0%)
11 (91.7%)
0 (0.0%)
0 (0.0%)
14.00
(13.0027.00)
2.80 (2.403.60)

3 (25.0%)
0 (0.0%)
17.00 (12.2519.75)
2.70 (2.433.43)

* indicates statistically significant
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1 (8.3%)
3 (25.0%)
21.50
(14.2525.75)
2.15 (2.003.05)

pvalue
0.027*

0.226
0.210
0.255
0.884
1.000
0.776
1.000
1.000
0.082
0.899
0.002*
0.413
0.106
0.432

0.382

Figure 2: MELD Score and Malnutrition
(In the moderate group, the highest MELD was excluded from the plot as
an outlier)

Based on the dietitian-conducted NFPE, 24 patients had a malnutrition diagnosis
of moderate or severe malnutrition. The results of the NFPE were then compared to
cirrhosis diagnosis, decompensation, patient outcomes, MELD score, and albumin level.
As a result of the small sample size (n=31), a Fisher’s Exact Test was used for analysis in
the majority of variables. A Mann-Whitney test was used when comparing albumin and
MELD scores. There was no relation between types of decompensation, MELD score, or
albumin levels and malnutrition (p > 0.05). However, higher median MELD scores were
found in those with malnutrition than those without. Median MELD score also increased
with severity of malnutrition. While albumin levels were not found to be significantly
associated with malnutrition, the median albumin levels were higher in the group without
malnutrition compared to those with malnutrition (2.80, 2.70 and 2.15 respectively). In
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addition to this, albumin levels decreased as severity of malnutrition increased (Table 6).
In comparison, disease diagnosis was found to be significantly related to malnutrition (p
= 0.027). Lastly, when comparing malnutrition to patient outcomes, only hospital
admission was found to be significantly associated with malnutrition (p = 0.002).
Additional analyses were conducted comparing presence of malnutrition and
severe malnutrition to hospital admissions due to the high level of significance found in a
previous analysis. A logistic regression analysis was conducted for each, and was
adjusted for age, gender, and albumin levels. The odds-ratio for hospital admission based
on malnutrition and severe malnutrition were both extremely high (14.571, 18.857
respectively) and were found to both be significant (p < 0.05). Caution is warranted in
interpreting these results, as the small sample size and increased variation, leads to wide
confidence intervals. Table 7 and 8 reflect these results.
Table 7: Hospital Admission and Malnutrition
Binary Logistic Regression on Hospital Admission
B
2.679
-1.792

Malnutrition
Constant

S.E.
1.170
1.080

Wald
5.245
2.752

Sig.
.022*
.097

95% C.I.for OR
OR
Lower Upper
14.571
1.472 144.280
.167

The variables age, gender and ALB were eliminated from the model after model selection.
*Indicates statistical significance

Table 8: Hospital Admission and Severe Malnutrition
Binary Logistic Regression on Hospital Admission

Severe Malnutrition
Constant

B
2.937
-.539

S.E.
1.148
.476

Wald
6.549
1.284

95% C.I.for OR
Sig.
OR
Lower
Upper
.010 18.857 1.989 178.796
.257
.583

The variables age, gender and ALB were eliminated from the model after model selection.
*Indicates statistical significance
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Comparison of NFPE to Additional Assessment Tools
Table 9: Malnutrition Compared to Additional Tools
Correlation
NFPE Results
Based on TPA
Based on L3 SMI
Less than 25% of L3
SGA stage

A
B
C

TSF-I
MAC-I

Malnutrition
N (n = 7)
Y (n = 21)*
2 (28.6%)
12 (57.1%)
6 (85.7%)
19 (90.5%)
0 (0.0%)
7 (33.3%)
N (n = 7)
Y (n = 24)
5 (71.4%)
0 (0.0%)
2 (28.6%)
13 (54.2%)
0 (0.0%)
11 (45.8%)
1 (14.3%)
5 (20.8%)
0 (0.00%)
0 (0.00%)

Spearman’s rho
0.247
0.067
0.333
Spearman’s rho
0.669

0.069
-

*3-missing CT
L3 SMI represents Lumbar Index

Table 10: Severe Malnutrition Compared to Additional Tools
Correlation
NFPE Results
Based on TPA
Based on L3 SMI
Less than 25% of L3
SGA stage

A
B
C

TSF-I
MAC-I

Severe Malnutrition
N (n = 19)
Y (n = 9)*
7 (36.8%)
7 (77.8%)
16 (84.2%)
9 (100.0%)
2 (10.5%)
5 (55.6%)
N (n = 7)
Y (n = 24)
5 (26.3%)
0 (0.0%)
13 (68.4%)
2 (16.7%)
1 (5.3%)
10 (83.3%)
3 (15.8%)
3 (25.0%)
0 (0.00%)
0 (0.00%)

Spearman’s rho
0.382
0.238
0.486
Spearman’s rho
0.760

0.114
-

*3-missing CT
L3 SMI represents Lumbar Index

In addition to the NFPE, multiple additional tools were used to assess
malnutrition in this study for comparison, including the Lumbar Index, psoas muscle
area, PG-SGA, TSF, and MAC. Three participants did not have a CT scan as part of their
evaluation, and their data was excluded for the CT/NFPE comparison portion of the
analysis. After using the CT scans to assess for sarcopenia, fourteen patients were shown
to have sarcopenia based on total psoas muscle area (TPA) and twenty-five participants
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were found to have sarcopenia using the Lumbar Index. There were six participants who
had a TSF below normal limits, which was considered malnourished. All participants had
a MAC that was found to be within normal limits, and therefore considered without
malnutrition. Out of the thirty-one participants, twenty-six participants were found to
have some degree of malnutrition (Stage B or C) based off of the PG-SGA, and eleven of
those participants were found to have severe malnutrition (Stage C). Tables 9 and 10
shows how each of the malnutrition assessment tools compared to the NFPE results.
A Spearman’s rho test (rs) was used to assess strength and direction of correlation
between each of these tools and the NFPE. A diagnosis of malnutrition versus no
malnutrition using the NFPE, was compared against whether or not malnutrition was
found using the TPA, L3 SMI, TSF, PG-SGA, and MAC. An additional analysis was run
comparing patients who had severe malnutrition using the NFPE, to the lowest quartile
measurements of TPA, L3 SMI, and TSF and Stage C of the PG-SGA. There was a
strong, positive correlation (rs = 0.669) between NFPE malnutrition and PG-SGA
classified malnutrition. This correlation was increased (rs = 0.760) when comparing
severe malnutrition using the NFPE to PG-SGA classified severe malnutrition (Stage C).
When comparing TPA and L3 SMI to NFPE classified malnutrition, there was a very
weak correlation between each test, except when comparing the bottom 25% quartile of
the L3 SMI to severe malnutrition using the NFPE. This resulted in a moderate
correlation (rs = 0.486) between the two measures. An additional test was completed to
compare L3 SMI measurements to NFPE malnutrition diagnosis. Table 11 reflects these
results. There was a significant (p = 0.027) association between L3 SMI and NFPE
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diagnosis of malnutrition. However, there was no correlation seen between L3 SMI and
severe malnutrition.
Table 11: L3 SMI and NFPE Malnutrition Diagnosis

Mean ± S.D.
Median (Q1, Q3)

Mean ± S.D.
Median (Q1, Q3)

L3 SMI (cm2/m2)
Malnutrition
N (n = 7)
Y (n = 21)†
45.01 ± 10.25
34.29 ± 10.23
46.72 (36.82, 48.99)
35.80 (29.78, 39.83)
Severe Malnutrition
N (n = 19)
Y (n = 9)†
38.91 ± 8.48
32.87 ± 15.04
37.57 (32.29, 43.16)
31.46 (24.73, 45.69)

†3-missing CT
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p-value
0.027*
0.385
p-value
0.357
1.000

Chapter 5: Discussion
Malnutrition is a very common medical condition that is seen in a variety of
settings. It can greatly affect patient outcomes and is often hard to diagnosis and assess.
This is mainly due to the wide variety of methods and techniques available, many of
which are often unreliable or inconsistent.[12] In 2012, the NFPE was developed for
dietitians to aid physicians in a nutrition-based diagnosis of malnutrition. Since its
development, there have been very few research studies using the NFPE.[13]
One particular setting that assessment of malnutrition is increasingly difficult, is
in patients with cirrhosis or ESLD. These patients are at high risk for developing
malnutrition due to a variety of disease-related side effects such as ascites, nutritional
deficiencies, and increased metabolic demand. The quest for a reliable and valid tool for
assessing malnutrition in ESLD, is an ever-growing topic in research.[4-10, 15, 17, 18,
22, 25, 28, 29] The purpose of this study was to assess malnutrition in ESLD patients
being evaluated for transplant. It is important to assess malnutrition in this patient
population because of the effect malnutrition has on mortality and pre/post-transplant
outcomes. ESLD patients have an increased of developing malnutrition and aggressive
nutrition intervention can greatly affect patient outcomes. This study assessed
malnutrition using a variety of tools and methods such as NFPE, Lumbar Index, TPA,
MAC, and TSF. The NFPE is advantageous over other tools because of how simple,
quick, and inexpensive the tool is compared to others and can be easily repeated. In
addition, the NFPE can be especially beneficial in this patient population since other
previously studied tools either were too expensive or unreliable in ESLD patients.
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Malnutrition was also examined in its relation to ESLD diagnosis, MELD,
decompensation, patient outcomes, and lab values.

Malnutrition Prevalence
Malnutrition was found in 77% of this patient population using the NFPE, in
comparison to 84% using PG-SGA, 19.3% using TSF, 50% using TPA, and 89.3% using
L3 SMI. These results reflect the high incidence of malnutrition in this patient population
and the wide variability in malnutrition diagnosis, mainly due to the lack of a
standardized, all-encompassing tool. However, many of these tools were correlated with
each other in determining malnutrition. These relationships will be further discussed in
the following sections.
Appetite changes and weight loss was also found in the majority of participants.
Both are risks factor for developing malnutrition. In comparison, less than half of these
patients were using protein supplements to supplement their decreased intake, and over a
quarter of this population had never had a previous diet education. This is alarming
considering the overwhelming occurrence of malnutrition in this patient population and
the prevalence of factors like decompensation that can greatly affect nutritional intake.
Especially since poor nutritional status is linked to poor outcomes before and after
transplant.[4-6, 8, 9] This indicates a need for earlier nutrition intervention to assist with
symptom management and proper nutrition therapy for ESLD patients.
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Malnutrition and Liver Disease
The relationship between the NFPE diagnosed malnutrition and ESLD diagnosis,
decompensation, and patient outcomes was also examined in this study. ESLD diagnosis
was found the be significantly associated with malnutrition diagnosis in this patient
population. There were not enough participants to determine which diagnosis was linked
to an increased risk of malnutrition. A larger sample size may further examine if certain
ESLD diagnoses increases the risk of developing malnutrition.
Although there was a significant association between ESLD diagnosis and
malnutrition, there were no decompensation characteristics that were linked to
development of malnutrition. However, a larger sample size may find an association
between specific decompensation symptoms and incidence of malnutrition.
Additionally, albumin levels, a common tool used to previously diagnose
malnutrition, had no significant correlation with the NFPE malnutrition diagnosis. While
median albumin levels were found to be higher in non-malnourished patients, there were
still a wide variation in albumin levels for each malnutrition categories. Albumin is not a
reliable indicator of nutritional status, which is also reflected in these results.
Similar to the albumin results, higher median MELD scores were shown in those
with malnutrition versus. those without. This could reflect the increased risk of
developing malnutrition as ESLD worsens or the possibility that the presence of
malnutrition worsens ESLD. While MELD has been found to be a good tool to predict
mortality in ESLD patients, it does not reflect additional factors that affect mortality such
as malnutrition. Possible future studies using a MELD score with a malnutrition
component should be considered.
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Malnutrition using the NFPE was also compared to patient outcomes such as
transplant listing, decompensation, hospital admission, transplant, and death. Only
hospital admissions were found to be correlated with a malnutrition diagnosis. There was
also an extremely high odds-ratio for hospital admission, which increased with the
severity of malnutrition. Patients with a diagnosis of malnutrition were roughly 1,400%
more likely to be admitted to the hospital, and roughly 1,900% more likely with a
diagnosis of severe malnutrition. However, due to the small patient population, this data
is limiting. More research will need to be conducted to evaluate this relationship. If
similar results are found in future studies, this could signify the importance of an earlier
nutrition intervention, including the RD screening for malnutrition and more aggressive
nutrition care, to prevent negative patient outcomes such as hospital admissions.

PG-SGA
Previous studies have used SGA to assess malnutrition in cirrhosis patients with
positive results. While the SGA and PG-SGA are not the exact same tool, the PG-SGA is
an expanded version of the SGA. In this study, the NFPE was found to be strongly
correlated with the PG-SGA in both diagnoses of malnutrition and severity of
malnutrition. In addition, the PG-SGA in this study, provided similar results to those that
were seen with the SGA in cirrhotic patients in other studies. [6, 15] In these previous
studies, malnutrition determined by the SGA, was also associated with poor patient
outcomes. This study found similar results when examining the role of NFPE identified
malnutrition and hospital admissions.

39

These results strengthen the NFPE as a valid tool to assess malnutrition in ESLD
patients. Additionally, the NFPE is a quick, simple tool compared to the PG-SGA and
can be conducted in a variety of settings. The PG-SGA relies heavily on patient recall
which could possibly skew results and could be inaccurate depending on literacy level or
patient understanding. In comparison, the NFPE is completed by a trained RD and patient
recall is only a small portion of the exam. The NFPE also relies heavily on the physical
exam, while the physical exam is only a small part of the PG-SGA. More research will
need to be conducted with the NFPE to study its validity.

TSF and MAC
TSF and MAC are standardized tools that have been used to assess malnutrition in
many studies involving cirrhotic patients. In this study, there were no patients that had a
MAC below normal limits to indicate malnutrition. Malnutrition was indicated in six
patients using TSF parameters. Both of these tools under-diagnosed malnutrition
compared to the NFPE and PG-SGA. This indicates that the TSF and MAC may not be
reliable tools to assess malnutrition in ESLD patients. The majority of this population
were overweight or obese, likely skewing the effectiveness of these tools. A larger
sample size may collaborate these results.

L3 SMI and TPA
Overall, sarcopenia was found in the majority of the patients in this study after
examining the TPA and L3 SMI. In comparison to the NFPE, there was a poor
correlation between most of the studies and the NFPE diagnosed malnutrition. However,
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moderate correlation was found between severe malnutrition using the NFPE and the
lowest quartile of the L3 SMI. It is likely that the correlation between these tests would
increase with a larger sample size. The mean L3 SMI was also found to be significantly
associated with malnutrition diagnosis. These are promising results. If the NFPE is found
to be a valid tool to measure sarcopenia, the ability to diagnose malnutrition in this
patient population would be substantially altered. Since sarcopenia is often masked in
these patients due to ascites and edema this would be of great benefit to those making
assessments. As with the previously discussed tools, future studies with larger sample
sizes, will need to be conducted.

Conclusion
In conclusion, malnutrition is a consistent problem in most patient populations.
There have been numerous tools used over the years used to diagnose malnutrition, but
many of these tools have been found to be unreliable and inconsistent. The need for a
standardized tool that encompasses a variety of measures and can be used in all patient
populations, has been ever-growing. In 2012, the NFPE was developed for dietitians to
aid physicians in a nutrition-focused malnutrition diagnosis. However, there have been
very few research studies using this NFPE to assess malnutrition.
Based on the results of this study, the validity of this tool is very promising. The
validity of the NFPE was examined by comparing its results to other malnutrition tools.
The NFPE has been shown to correlate with other tools such as the invasive L3 SMI
measure for sarcopenia and the PG-SGA/SGA, which has been validated in other studies.
In addition, the NFPE diagnosed malnutrition was found to be significantly associated
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with hospital admissions. Due to the small patient population of this study, more research
will need to be conducted to support these results.
Sample size and number of patients without malnutrition were limitations to this
study. The majority of the patients examined were white and males, therefore limiting the
generalizability of the results. The NFPE was also limited in this study from inability to
collect data on all physical locations due to ascites, clothing, or injury. There was also
likely inaccuracy in assessing weight status and energy intake due to patient recall. While
there were many limitations in this study, the use of multiple malnutrition tools for
comparison was a strength in this study. These tools were comprised of both objective
and subjective tools which was another strength. Additionally, inclusion/exclusion
criteria and patient randomization between RDs limited possible biases. Lastly,
comparing NFPE-diagnosis to patient outcomes showed the benefits of using this tool.
These preliminary results reinforce the significance of the NFPE and the need for
additional studies using this tool. The NFPE also stresses the importance of the RD in the
medical field, and how an earlier dietitian screening and intervention could improve
patient outcomes, such as reduced hospital admissions, reduced incidence and severity of
malnutrition, and decreased risk of mortality, especially in patients with ESLD.
Furthermore, using MELD score to predict mortality in ESLD patients needs to be reevaluated. As compared to previous research, MELD is not associated with liver disease
diagnosis or incidence of malnutrition. However, adding a nutritional component to
MELD scoring could potentially improve the accuracy of mortality risk and prioritization
of transplant patients on the wait list. More research using the NFPE will need to be
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conducted in not only ESLD patients, but other patient populations, before the NFPE can
be considered the “gold standard” for diagnosing malnutrition.
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Appendix A: List of Abbreviations
Abbreviation
AND
ASPEN
CTP
ESLD
EV
HCC

Explanation
Academy of Nutrition and Dietetics
American Society for Parenteral and Enteral Nutrition
Child-Turcotte-Pugh Score
End Stage Liver Disease
Esophageal Varices
Hepatocellular Carcinoma

HE

Hepatic Encephalopathy

HRS

Hepatorenal Syndrome

L3 PMI

Lumbar Psoas Muscle Index

L3 SMI

Lumbar Index

LVP

Large Volume Paracentesis

MAC

Mid-Arm Circumference

MAMC

Mid-Arm Muscle Circumference

MELD

Model for End Stage Liver Disease

NAFLD

Non-Alcoholic Fatty Liver Disease

NASH

Non-Alcoholic Steatohepatitis

NFPE

Nutrition Focused Physical Exam

PG-SGA

Patient Generated-Subjective Global Assessment

RFH-GA

Royal Free Hospital Global Assessment

RD

Registered Dietitian

SBP

Spontaneous Bacterial Peritonitis

SGA

Subjective Global Assessment

TIPS

Transjugular Intrahepatic Portosystemic Shunt
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TSF

Triceps Skin Folds

UNOS

United Network for Organ Sharing

Appendix B: NFPE: Clinical Characteristics to Identify and Support a Diagnosis of
Malnutrition[26]
Clinical
Characteristic

Energy Intake

Interpretation
of Weight
Loss

Malnutrition in the context of
acute illness or injury
Non-severe
(moderate)
malnutrition

Severe
Malnutrition

<75% of
estimated
energy
requirement
for > 7 days

< 50% of
estimated
energy
requirement
for  5 days

Malnutrition in the context
of chronic illness
Non-severe
(moderate)
malnutrition
< 75% of
estimated
energy
requirement
for  1
month
%
Time

%

Time

%

Time

1-2

1 week

>2

1 week

5
7.5

1
month
3
months

>5
>7.5

1
month
3
months

5
7.5
10
20

Severe
Malnutrition
< 75% of
estimated
energy intake
for  1
month
%

Time

1
month
3
months
6
months

>7.5

1 year

>20

>5

>10

Malnutrition in the context of
social or environmental
circumstances
Non-severe
Severe
(moderate)
Malnutrition
malnutrition
< 75% of
£ 50% of
estimated
estimated
energy
energy
requirement
requirement
for  3
for  1
months
month
%
Time
%
Time

1
month
3
months
6
months

>7.5

1 year

>20

>5

>10

1
month
3
months
6
months

>7.5

1 year

>20

>5

>10

1
month
3
months
6
months
1 year

Physical Findings
Body Fat

Mild

Moderate

Mild

Severe

Mild

Severe

Muscle Mass

Mild

Moderate

Mild

Severe

Mild

Severe

Mild

Severe

Mild

Severe

N/A

Measurably
Reduced

N/A

Measurably
Reduced

Fluid
Accumulation
Reduced Grip
Strength

Mild
N/A

Moderate to
Severe
Measurably
Reduced
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Appendix C: Summary of Common Liver Disease Diagnoses[2, 3]
Type of Liver
Disease

Hepatitis B and C

Cause of Liver
Disease

Hepatitis is a virus
that can be
transmitted through
bodily fluids (semen,
blood, and vaginal
secretions)

At Risk
Populations/Risk
Factors

Treatment/Cure

• IV drug use
• Unprotected sex
• Body piercings
• Tattoos
• Incarceration

• Hepatitis can be cured spontaneously by
the body and through pharmaceuticals.
• There is currently a vaccine for
Hepatitis B, but not for Hepatitis C.
• When a patient with the hepatitis virus
fails treatment, or waits too long to seek
treatment, it can lead to liver damage and
ultimately liver failure. This can only be
treated with transplant.

• High
acetaminophen
use
• Herbal use
• Cancers with
high risk of liver
metastasis
development
• Liver Cancer
• Metabolic
Disorders
• Women
between the ages
15-40
• Other
autoimmune
diseases
• Alcoholics
• Those with long
history of
frequent alcohol
use

Acute Liver Failure

Drug overdose
(acetaminophen),
drug
toxicity/reaction,
herbal supplements,
viruses, cancer,
metabolic diseases

Autoimmune
Hepatitis

Immune system
attacks liver cells
causing inflammation
and damage

Alcoholic Liver
Disease

Alcohol abuse

Nonalcoholic Fatty
Liver
Disease/Nonalcoholic
Steatohepatitis

Build-up of fat cells
in the liver

• Obesity
• Diabetes
• High cholesterol
• Unhealthy diet

• Healthy diet and exercise
• Weight loss if overweight/obese
• Transplant

Hepatocellular
Carcinoma

Liver Cancer

• Pre-existing
cirrhosis
• Long term
hepatitis virus

• Resection
• Chemoembolization
• Ablation
• Treatment of hepatitis or underlying
cirrhosis
• Transplant

Primary Biliary
Cirrhosis

Destruction of
intrahepatic bile
ducts leads to build

• Women
• Middle age

• Symptom management with
medications
• Transplant
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• Medications to reverse poisoning
• Transplant

• Suppress immune system with steroids
or other immunosuppressant drugs
• Transplant

• Alcohol cessation
• Transplant

up of bile and scar
tissue, damaging the
liver.

adults
• Genetics

Primary Sclerosis
Cholangitis

Blocked bile ducts
due to scar tissue and
inflammation leads to
buildup of bile,
damaging the liver.

• Men
• Genetics
• Exact cause
unknown

• Symptom management with
medications and surgery
• Transplant

Other (less common)

Wilson’s Disease,
Hemochromatosis,
Alpha-1
Anti-trypsin
Deficiency,
Undetermined cause,
etc.

• Genetics
• Lifestyle

• Treatment based on disease.
• Transplant

Appendix D: Age, Sex, Race, MELD, BMI, and Albumin Characteristics of Study
Sample

Age
Sex

Male
Female
Race
Caucasian
African-American
MELD
BMI
Albumin (g/dL)

n
24
7
30
1
-

%
77.4%
22.6%
96.8%
3.2%
-

Median
54
18
28.8
2.7
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Std. Deviation
9.9
6.63
6.62
0.73

Min
29
7
15.8
1.3

Max
69
34
43.9
4.0
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